Overtreatment in cancer care, especially near the end of life, is a growing issue. David Kerr, a cancer medicine professor at the University of Oxford, reflects on a review by his colleague Nathan Cherny. The review provides important insights into the harmful effects of overtreatment in cancer patients and suggests ways to improve care. Overtreatment occurs when cancer patients near the end of life receive aggressive therapies, such as chemotherapy, that are unlikely to help. These treatments can cause unnecessary side effects, harm, and financial burden without improving quality of life. Overtreatment also affects patients and doctors emotionally. Patients may fear that stopping active treatment means they’re giving up on life. This can make them resist switching to palliative care, even when it could improve their quality of life. For oncologists, there’s an emotional bond with patients, making it hard to stop treatments even when they know they won’t help. Oncologists sometimes hold on to the hope that small chances of success might still exist. The internet also plays a role. Patients might find unverified medical information online, which can make them more eager to continue treatment, even if it’s not useful. Kerr stresses the importance of understanding these feelings and says that oncologists should work alongside their patients in navigating these tough decisions. One key solution is improving communication skills for doctors, especially those in training. They need to be able to have open, honest discussions with patients about stopping active treatments and transitioning to palliative care. This approach could help patients see palliative care as a way to improve their remaining time, rather than as a sign of giving up. Clear communication can help make end-of-life discussions more positive. Guidelines from organizations like the American Society of Clinical Oncology (ASCO) should emphasize integrating palliative care early on and work with patient advocacy groups to change how palliative care is viewed. It should not be seen as a last resort but as an important part of treatment. Health policies should also focus on improving quality of life, caregiver support, and allowing patients to spend more time at home. Instead of investing in treatments that offer little benefit, the focus should be on improving well-being.
David Kerr urges healthcare professionals to read Cherny’s article for insights on overtreatment and its emotional and social impacts. Cherny’s expertise offers valuable perspectives on how to balance aggressive treatment with quality of life during a patient’s final stages. Kerr calls for more research, better communication training, and policy changes to improve care for cancer patients nearing the end of life. By focusing on quality of life, doctors and patients can face this difficult time with dignity and clarity.